Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer

NCT03146637 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
80
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Collaborators